ARISTOMOL

This brand name is authorized in Nigeria.

Active ingredients

The drug ARISTOMOL contains one active pharmaceutical ingredient (API):

1	Timolol UNII P8Y54F701R - TIMOLOL MALEATE
	Timolol is a non-selective beta-adrenergic receptor blocking agent that does not have significant intrinsic sympathomimetic, direct myocardial depressant, or local anaesthetic activity. Timolol reduces intra-ocular pressure, whether or not this is associated with glaucoma.
	Read more about Timolol

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-3508	Solution/Drops	Aristomol Eye Drops SOL_DROPS 0.5% 5 mL (in plastic dropper bottle)	Timolol Eye Drops BP 0.5% w/v Each mL contains: Timolol Maleate BP equivalent to Timolol base 5 mg	28/10/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01ED01	Timolol	S Sensory organs → S01 Ophthalmologicals → S01E Antiglaucoma preparations and miotics → S01ED Beta blocking agents
Discover more medicines within S01ED01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-3508